News & Articles

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020

Visit booth 3624 to meet the team, pick up a free T-shirt and join in the musical fun as popular singer Alexander Joseph returns with his grand piano

Researchers use 3D cell culture to uncover the link between vitamin D deficiency and intestinal stem cells

Drop by SelectScience booth #205 at the SLAS2020 conference January 27-29

This collaboration promises to develop stem cell therapies for life-threatening diseases

Sechenov University and the University College Cork have developed a method for studying mitochondrial polarization in live cells and tissues

AMSBIO is advancing stem cell discovery with the GenePORTER 2 reagent for transfection

AMSBIO has found a reagent to best transfect its human embryonic stem cells

Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies

Options to vacuum filter smaller volumes of 50mL at high speeds resolve time-consuming steps in cell line development

Researcher Meritxell Huch awarded the BINDER Innovation Prize

The eCHO™ Medium is ideal for the manufacture of recombinant proteins for medical use, including monoclonal antibodies and complex glycoproteins

Integration of S-LAB with the Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development

Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization

Ultra-clean deep well and assay microplates to be showcased at the Lab Innovations 2019 exhibition

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

99 problems? Cell culture doesn’t have to be one of them

Dr. John Connolly, CSO of Tessa Therapeutics, reveals how a new approach to cell-based therapy in cancer could circumvent severe immunotherapy side effects and effectively target aggressive solid tumors

Learn how one biotechnology company is using cutting-edge imaging to improve the visualization of angiogenesis in its 3D tissue models

Solutions for automation, assay development, high-throughput screening, imaging and more